Cargando…
Intracolonic Administration of Vancomycin in Intensive Care Unit Patients with Severe Clostridium Difficile Colitis
Background: Clostridium difficile infection (CDI) is a major cause of antibiotic-associated diarrhea worldwide. The incidence of sepsis has been shown to be increasing due to severe or fulminant colitis. Oral vancomycin is the treatment of choice for CDI, but it is often ineffective in patients in t...
Autores principales: | Teixeira, Alex, Tripathi, Kartikeya, Greeff, Yesenia, Sorour, Omar, Mccallion, Paul, Davis, Garrison, Sorour, Khaled |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749802/ https://www.ncbi.nlm.nih.gov/pubmed/33364098 http://dx.doi.org/10.7759/cureus.11573 |
Ejemplares similares
-
The efficacy of intracolonic vancomycin for severe Clostridium difficile colitis: a case series
por: Akamine, Christine M., et al.
Publicado: (2016) -
Outcomes of Continuous Enteral Vancomycin Infusion in Intensive Care Unit Patients: A Novel Treatment Modality for Severe Clostridium Difficile Colitis
por: Peters, Haley, et al.
Publicado: (2022) -
Comparison of Fidaxomicin and Vancomycin for Recurrent Clostridium difficile Colitis
por: Khoo, Teresa, et al.
Publicado: (2017) -
Fulminant Pseudomembranous Colitis Presenting as Sigmoid Stricture and Severe Polyposis with Clinical Response to Intracolonic Vancomycin
por: Cheung, Sai Wah, et al.
Publicado: (2016) -
Ischemic Colitis Is a Risk Factor for Clostridium difficile Infection
por: Khazaaleh, Shrouq, et al.
Publicado: (2022)